UK markets closed

Fresenius Medical Care AG & Co. KGaA (FMCQF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
39.770.00 (0.00%)
At close: 12:38PM EST

Fresenius Medical Care AG & Co. KGaA

Else-KrOener-Strasse 1
Bad Homburg 61352
49 6172 609 0

IndustryMedical Care Facilities
Full-time employees123,106

Key executives

NameTitlePayExercisedYear born
Ms. Helen GizaCEO & Chair of Management Board of Fresenius Med. Care Mgmt AG3.53MN/A1968
Dr. Franklin W. Maddux F.A.C.P.Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG2.65MN/A1957
Mr. William J. ValleManagement Board Member for Care Delivery of Fresenius Medical Care Management AG4.31MN/A1960
Dr. Katarzyna Mazur-Hofsab Ph.D.Management Board Member for Care Enablement of Fresenius Medical Care Management AG2.57MN/A1963
Mr. Roberto FusteExecutive Advisor for Regional StrategyN/AN/A1952
Mr. Martin FischerCFO & Member of the Management Board of Fresenius Medical Care Management AGN/AN/A1977
Dr. Dominik HegerExecutive VP and Head of Investor Relations, Strategic Development & CommunicationsN/AN/AN/A
Mr. Borries Von MullerSenior Vice President of Global Human Resources Employee CommunicationsN/AN/A1961
Mr. Joachim WeithSenior Vice President of Corporate Communications & Governmental AffairsN/AN/AN/A
Mr. Oliver MaierSenior Vice President Investor RelationsN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Corporate governance

Fresenius Medical Care AG & Co. KGaA’s ISS governance QualityScore as of 28 November 2023 is 7. The pillar scores are Audit: 2; Board: 4; Shareholder rights: 1; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.